The Overall Objective is to improve the enabling regulatory environment for medicinal products including vaccines in Egypt and promote Egyptian Drug Authority to become a World Health Organisation (WHO) – listed Authority (WLA).
The Specific objective is to support the Egyptian Drug Authority (EDA) to reach WHO Global Benchmarking Tool (GBT) Maturity Level 4 for Medicinal Products, including vaccines, and to comply with WHO Good Regulatory Practices up to the level of a Stringent Regulatory Authority (SRA).
Syria